Home -> Law Blog Directory -> Intellectual Property Law Blogs -> Orange Book Blog: At the Intersection of Patent Law and FDA Law

Intellectual Property Law

: Orange Book Blog: At the Intersection of Patent Law and FDA Law

BNA "Pharmaceutical Patent Laws" Conference, Arlington, VA, November 12

By Aaron Barkoff

BNA Legal & Business Edge is presenting a conference entitled "Pharmaceutical Patent Laws:  A Prescription for Success in Challenging Times, November 12 in Arlington, VA.

According to BNA, this will be a "fast-paced conference on the latest developments and changes in pharmaceutical patent law."

Here's the agenda:

• Morning Keynote Address:  Inequitable Conduct
• "Pay for Delay" and Other Continuing Controversies in Pharmaceutical Patent Settlements
• Non-Patent Marketing Exclusivity
• Import and Export Issues
• Luncheon Keynote Address:  Two Legislative Currents Driving Biotech Patent Law Reform
• The Other Kind of Pharmaceutical IP:  Regulatory Life Cycle Management Strategies--Opportunities and Challenges
• Pharma Post-Election:  Predictions for the Future
• Trends in Declaratory Judgment Actions:  Where are the Courts Headed?

For more information or to register, please visit the conference website.

BNA is offering a special discount to Orange Book Blog readers:  40% off the registration fees; and, if you register two people at the discounted rate, a third registration will be free.  Enter code CONF40NE when registering, or email Nancy Erikson at NErickson@bna.com.

Full post as published by Orange Book Blog: At the Intersection of Patent Law and FDA Law on October 18, 2008 (boomark / email).